Research Analysts' Updated EPS Estimates for January 25th (ABT, AJB, BKR, BTCS, CRE, CSX, CVSG, EPWN, ETD, FCX)
Research Analysts’ updated eps estimates for Thursday, January 25th: Abbott Laboratories (NYSE:ABT) had its outperform rating reiterated by analysts at Royal Bank of Canada. Royal Bank of Canada currently has a $128.00 price target on the stock. AJ Bell (LON:AJB) had its buy rating reissued by analysts at Shore Capital. Baker Hughes (NASDAQ:BKR) had its […]